CME Group (CME) 10-K Summary — Year Ended Dec 31, 2024
CME Group operates a global derivatives exchange and clearinghouse. The company reported higher revenue and operating income for the latest annual period compared to the prior year.
Key takeaway
Year ended Dec 31, 2024 · FY2025 10-K
CME Group operates a global derivatives exchange and clearinghouse. The company reported higher revenue and operating income for the latest annual period compared to the prior year.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$6.1B
Revenue reported for the fiscal year.
Operating income
$3.9B
Income from operations reported for the year.
Net income
$3.5B
Net income reported for the year.
Operating cash flow
$3.7B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2021 | $4.7B | n/a |
| Dec 31, 2022 | $5B | +7.0% |
| Dec 31, 2023 | $5.6B | +11.1% |
| Dec 31, 2024 | $6.1B | +9.9% |
Business overview
CME Group is a holding company for designated contract markets that trade futures and options contracts. It also clears futures, options, and swaps through its clearing house. Customers include professional traders, financial institutions, corporations, and governments worldwide.
Financial performance
Revenue increased compared to the prior year, continuing a multi-year growth trend. Operating income and net income were reported at healthy levels, and operating cash flow remained robust.
Material risks
The filing references a risk factors section, but no specific risks are detailed in the supplied context.
Liquidity and capital
The filing discusses liquidity and capital resources, but no specific details are available in the supplied context.
What to watch
Monitor whether the company's revenue growth continues in the next reporting period.